A detailed history of United Bank transactions in Biogen Inc. stock. As of the latest transaction made, United Bank holds 3,636 shares of BIIB stock, worth $546,090. This represents 0.33% of its overall portfolio holdings.

Number of Shares
3,636
Previous 3,762 3.35%
Holding current value
$546,090
Previous $872,000 19.27%
% of portfolio
0.33%
Previous 0.44%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$189.07 - $236.8 $23,822 - $29,836
-126 Reduced 3.35%
3,636 $704,000
Q2 2024

Jul 23, 2024

BUY
$190.52 - $236.72 $55,060 - $68,412
289 Added 8.32%
3,762 $872,000
Q1 2024

May 10, 2024

BUY
$212.02 - $267.71 $109,402 - $138,138
516 Added 17.45%
3,473 $748,000
Q4 2023

Feb 13, 2024

SELL
$222.59 - $267.94 $20,478 - $24,650
-92 Reduced 3.02%
2,957 $765,000
Q3 2023

Oct 27, 2023

BUY
$253.3 - $285.89 $146,154 - $164,958
577 Added 23.34%
3,049 $783,000
Q2 2023

Aug 07, 2023

BUY
$275.25 - $318.06 $93,860 - $108,458
341 Added 16.0%
2,472 $704,000
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $546,729 - $622,976
2,131 New
2,131 $592,000
Q1 2020

May 08, 2020

SELL
$268.85 - $341.04 $627,764 - $796,328
-2,335 Closed
0 $0
Q4 2019

Feb 03, 2020

SELL
$220.06 - $304.07 $105,408 - $145,649
-479 Reduced 17.02%
2,335 $693,000
Q3 2019

Nov 08, 2019

BUY
$217.44 - $243.88 $1,087 - $1,219
5 Added 0.18%
2,814 $655,000
Q2 2019

Jul 22, 2019

BUY
$219.29 - $241.72 $179,379 - $197,726
818 Added 41.08%
2,809 $657,000
Q1 2019

May 01, 2019

SELL
$216.71 - $338.96 $79,965 - $125,076
-369 Reduced 15.64%
1,991 $471,000
Q4 2018

Feb 11, 2019

SELL
$278.5 - $352.75 $119,755 - $151,682
-430 Reduced 15.41%
2,360 $710,000
Q3 2018

Nov 05, 2018

SELL
$293.51 - $383.83 $100,673 - $131,653
-343 Reduced 10.95%
2,790 $986,000
Q2 2018

Aug 09, 2018

BUY
$257.52 - $306.91 $105,325 - $125,526
409 Added 15.01%
3,133 $909,000
Q1 2018

May 07, 2018

SELL
$260.13 - $367.91 $79,599 - $112,580
-306 Reduced 10.1%
2,724 $746,000
Q4 2017

Feb 07, 2018

SELL
$307.64 - $344.58 $15,997 - $17,918
-52 Reduced 1.69%
3,030 $965,000
Q3 2017

Nov 08, 2017

BUY
$281.15 - $329.69 $866,504 - $1.02 Million
3,082
3,082 $965,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.6B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track United Bank Portfolio

Follow United Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Bank with notifications on news.